There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
82460.39 Cr.Face value
1.00Book value
380.22Div. yield
0.000P/E ratio
46.34P/B ratio
5.25Debt/Eq.
0.58Market Cap
82460.39 Cr.Face value
1.00Book value
380.22Div. yield
0.00%P/E ratio
46.34P/B ratio
5.25Debt/Eq.
0.58
| Dec 25 | Sep 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 72.66% | 72.67% | -0.01% |
| Promoter Pledge | 0.00% | 0.00% | 0.00% |
Mankind Pharma was incorporated on July 3, 1991 as a private limited company under the Companies Act, 1956, with the name ‘Mankind Pharma Private Limited’, pursuant to a certificate of incorporation granted by the Registrar of Companies, Delhi and Ha Read more 
Mankind Pharma develops, manufactures and markets pharmaceutical formulations across multiple therapies, and offers consumer healthcare products such as condoms, pregnancy kits, vitamins, antacids and medicated anti-acne preparations. It serves both domestic and international markets through a network of subsidiaries and extensive manufacturing and R&D facilities.
As on March 31, 2025, Mankind Pharma had 38 subsidiaries across India and international markets, including the US, Singapore, UAE, Germany, Malaysia and the Philippines.
International revenue contributed 13% of turnover in FY 2024-25, while 87% came from domestic operations.
